CYTOPLASMIC MYOSIN FUNCTION IN VITRO AND IN VIVO
CYTOPLASMIC MYOSIN FUNCTION IN VITRO AND IN VIVO
批准号:
3283912
负责人:
DANIEL PETER KIEHART
金额:
$17.83万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1984
资助国家:
美国
项目状态:
已结题
起止时间:
1984-09-30 至 1992-08-31
关键词:
Drosophilidae binding proteins cell motility cytogenetics cytoplasm cytoskeletal proteins electron microscopy eukaryote fluorescent dye /probe genetic transcription immunochemistry in situ hybridization invertebrate locomotion isozymes laboratory mouse laboratory rabbit microinjections molecular biology monoclonal antibody myosins phagocytosis pinocytosis tissue /cell culture
中文摘要
我们的长期目标是在分子水平上理解,
细胞质肌球蛋白的体内外作用机制
并确定哪些细胞运动需要肌球蛋白
部队生产。我们关注的是细胞质肌球蛋白的功能。
有两个原因。首先,一系列不同的
有趣的运动为空间提供了结构基础
胚胎的分化,并具有各种不同的特点
在其他细胞中看到的运动。它们包括核部门和
迁移,极细胞的形成和细胞化,以及
原肠胚复杂的细胞迁移和形态变化。
此外,这些运动可以通过一系列的研究来研究
强大的方法。我们使用了经典的蛋白质生化和
细胞质纯化和鉴定的免疫学方法
果蝇细胞培养中的肌球蛋白。这种蛋白质是肌球蛋白
五个结构标准和三个功能标准。它有别于
肌球蛋白重链异构体的多肽图谱和
免疫化学标准。这种有机体的真正优势是
当然,它可获得遗传、分子生物学和
现代分子遗传操作。我们用抗体来
果蝇基因组DNA文库的筛选及表达
载体lambda gtll,并分离出该基因的一段
编码细胞质肌球蛋白。它的基因产品具有相同的表位
具有细胞质而不是肌肉肌球蛋白重链
与7.4kb的消息混合,该消息足够大到
编码这个205kD的多肽。杂交研究与
果蝇DNA的限制性内切酶片段及其编码克隆
肌肉肌球蛋白重链证实它不是
肌肉肌球蛋白基因。此外,印度的初步测绘研究
与多线染色体的原位杂交表明,该基因
映射到60E,F,与肌肉肌球蛋白的位置不同
重链基因。在这里,我们提出了一个多学科的方法
对细胞质肌球蛋白的分析,包括进一步
细胞质肌球蛋白功能的体外鉴定,
该蛋白在胚胎和细胞中的定位、SITE的使用
用特异性抗体评价肌球蛋白的体外和体外功能
活体,编码这种多肽的基因的特征和
其转录单位、胞浆肌球蛋白重链的合成
或其片段在细菌和真核表达载体中的表达
蛋白质结构/功能的详细分析系统
细胞质的体外关系和遗传操作
培养细胞转化活细胞和胚胎中的肌球蛋白
P-元件介导的种系转化。同舟共济
这些研究伪造了一项关于
胞浆肌球蛋白的作用机制及其在细胞内的作用
动静。
英文摘要
Our long range goals are to understand, on the molecular level,
the mechanism of cytoplasmic myosin function in vitro and in vivo
and to determine which cellular movements require myosin for
force production. We focus on the function of cytoplasmic myosin
in Drosophila for two reasons. First, a diverse array of
interesting movements provide the structural basis for spatial
differentiation of the embryo and are characteristic of various
movements seen in other cells. They include nuclear divisions and
migrations, pole cell formation and cellularization, and the
complex cellular migrations and shape changes of gastrulation.
Moreover, these movements are amenable to study by a range of
powerful approaches. We used classical protein biochemical and
immunological methods to purify and characterize cytoplasmic
myosin from Drosophila cells in culture. This protein is myosin by
five structural and three functional criteria. It is distinct from
the muscle myosin heavy chain isoform by peptide mapping and
immunochemical criteria. The real advantage of this organism is
of course its accessibility to genetic, molecular biological and
modern molecular genetic manipulation. We used antibodies to
screen a library of Drosophila genomic DNA in the expression
vector lambda gtll and have isolated a fragment of the gene that
encodes cytoplasmic myosin. Its gene product shares epitopes
with cytoplasmic but not muscle myosin heavy chain and
hybridizes with a 7.4 kb message that is sufficiently large to
encode this 205 kD polypeptide. Hybridization studies with
restriction fragments of Drosophila DNA and clones that encode
muscle myosin heavy chain confirm that it is not part of the
muscle myosin gene. Moreover, preliminary mapping studies by in
situ hybridization with polytene chromosomes show that this gene
maps to 60E,F, distinct from the location of the muscle myosin
heavy chain gene. Here we propose a multidisciplinary approach
to the analysis of cytoplasmic myosin that includes further
characterization of cytoplasmic myosin function in vitro,
localization of this protein in embryos and cells, the use of site
specific antibodies to evaluate myosin function in vitro and in
vivo, characterization of the gene that encodes this peptide and
its transcription unit, synthesis of cytoplasmic myosin heavy chain
or its fragments in bacterial and eukaryotic expression vector
systems for detailed analysis of protein structure/function
relationships in vitro, and genetic manipulation of cytoplasmic
myosin in living cells and embryos by cultured cell transformation
and P-element mediated germ line transformation. Together
these studies forge a comprehensive investigation of the
mechanism of cytoplasmic myosin function and its role in cellular
movements.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Morphogenesis: Biophysics and Genetics of Dorsal Closure
-
批准号:10200838
-
项目类别:
-
资助金额:$43.61万
-
财政年份:2018
-
负责人:DANIEL PETER KIEHART
-
依托单位:
Morphogenesis: Biophysics and Genetics of Dorsal Closure
-
批准号:10623612
-
项目类别:
-
资助金额:$51.74万
-
财政年份:2018
-
负责人:DANIEL PETER KIEHART
-
依托单位:
Morphogenesis: Biophysics and Genetics of Dorsal Closure
-
批准号:10441492
-
项目类别:
-
资助金额:$43.57万
-
财政年份:2018
-
负责人:DANIEL PETER KIEHART
-
依托单位:
Design and Implementation of Genetically Encoded Myosin Based Force Sensors
-
批准号:8446280
-
项目类别:
-
资助金额:$18.38万
-
财政年份:2012
-
负责人:DANIEL PETER KIEHART
-
依托单位:
Design and Implementation of Genetically Encoded Myosin Based Force Sensors
-
批准号:8320666
-
项目类别:
-
资助金额:$21.88万
-
财政年份:2012
-
负责人:DANIEL PETER KIEHART
-
依托单位:
Morphogenesis: Biophysics and Genetics of Dorsal Closure
-
批准号:7923503
-
项目类别:
-
资助金额:$28.75万
-
财政年份:2009
-
负责人:DANIEL PETER KIEHART
-
依托单位:
Myosins VIIA, VIIB & XV in Fly Hearing and Morphogenesis
-
批准号:7252027
-
项目类别:
-
资助金额:$33.03万
-
财政年份:2005
-
负责人:DANIEL PETER KIEHART
-
依托单位:
Myosins VIIA, VIIB & XV in Fly Hearing and Morphogenesis
-
批准号:6964907
-
项目类别:
-
资助金额:$35.35万
-
财政年份:2005
-
负责人:DANIEL PETER KIEHART
-
依托单位:
Myosins VIIA, VIIB & XV in Fly Hearing and Morphogenesis
-
批准号:7640647
-
项目类别:
-
资助金额:$32.39万
-
财政年份:2005
-
负责人:DANIEL PETER KIEHART
-
依托单位:
Myosins VIIA, VIIB & XV in Fly Hearing and Morphogenesis
-
批准号:7456402
-
项目类别:
-
资助金额:$32.5万
-
财政年份:2005
-
负责人:DANIEL PETER KIEHART
-
依托单位:
Myosins VIIA, VIIB & XV in Fly Hearing and Morphogenesis
-
批准号:7094070
-
项目类别:
-
资助金额:$34.12万
-
财政年份:2005
-
负责人:DANIEL PETER KIEHART
-
依托单位:
MOLECULAR GENETIC ANALYSIS OF WOUND HEALING--DROSOPHILA
-
批准号:6387149
-
项目类别:
-
资助金额:$23.1万
-
财政年份:2000
-
负责人:DANIEL PETER KIEHART
-
依托单位:
MOLECULAR GENETIC ANALYSIS OF WOUND HEALING--DROSOPHILA
-
批准号:6090924
-
项目类别:
-
资助金额:$28.44万
-
财政年份:2000
-
负责人:DANIEL PETER KIEHART
-
依托单位:
MOLECULAR GENETIC ANALYSIS OF WOUND HEALING--DROSOPHILA
-
批准号:6526080
-
项目类别:
-
资助金额:$23.1万
-
财政年份:2000
-
负责人:DANIEL PETER KIEHART
-
依托单位:
CYTOPLASMIC MYOSIN FUNCTION IN VITRO
-
批准号:2177155
-
项目类别:
-
资助金额:$28.77万
-
财政年份:1984
-
负责人:DANIEL PETER KIEHART
-
依托单位:
CYTOPLASMIC MYOSIN FUNCTION IN VITRO
-
批准号:2770930
-
项目类别:
-
资助金额:$27.04万
-
财政年份:1984
-
负责人:DANIEL PETER KIEHART
-
依托单位:
CYTOPLASMIC MYOSIN FUNCTION IN VITRO AND IN VIVO
-
批准号:3283907
-
项目类别:
-
资助金额:$1.41万
-
财政年份:1984
-
负责人:DANIEL PETER KIEHART
-
依托单位:
CYTOPLASMIC MYOSIN FUNCTION IN VITRO AND IN VIVO
-
批准号:3283910
-
项目类别:
-
资助金额:$20.36万
-
财政年份:1984
-
负责人:DANIEL PETER KIEHART
-
依托单位:
CYTOPLASMIC MYOSIN FUNCTION IN VITRO AND IN VIVO
-
批准号:3283906
-
项目类别:
-
资助金额:$30.7万
-
财政年份:1984
-
负责人:DANIEL PETER KIEHART
-
依托单位:
CYTOPLASMIC MYOSIN FUNCTION IN VITRO AND IN VIVO
-
批准号:3283911
-
项目类别:
-
资助金额:$19.53万
-
财政年份:1984
-
负责人:DANIEL PETER KIEHART
-
依托单位:
海外基金